Methylphenidate (Ritalin) is a psychostimulant drug approved for treatment of ADHD or attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation). It was first licensed by the FDA in 1955 for treating ADHD, prescribed from 1960, and became heavily prescribed in the 1990s, when the diagnosis of ADHD itself became more widely accepted.
You may also like
About the author
Information to enrich your life.
WELCOME TO RICHTOPIA
- 2,457,819 all-time users
- Africa Exclusive: Property Investment in Lagos, Nigeria
- 11 Amazing Examples of Disruptive Technology
- 7 Wealth Habits of the World’s Richest People
- What Is Social Marketing? And How Does It Work?
- 17 Great Examples of Effective Leadership and Strategy
- Review of the 6 Major Blockchain Protocols
- 6 Key Attitudes of Successful Leaders
- Tourism, Nationalism and the De-Cosmopolitanisation of Culture in Bali